XML 46 R33.htm IDEA: XBRL DOCUMENT v3.24.0.1
Summary of Business and Significant Accounting Policies - Additional Information (Details)
$ in Thousands, shares in Millions
1 Months Ended 12 Months Ended
Sep. 21, 2021
Dec. 31, 2023
USD ($)
Segment
Dec. 31, 2022
USD ($)
Dec. 31, 2021
USD ($)
shares
Financing Receivable Impaired [Line Items]        
Unrecognized transaction price   $ 239,400    
Operating segment | Segment   1    
Reportable segment | Segment   1    
General and administrative expenses   $ 54,887 $ 53,636 $ 55,370
Allowance for doubtful accounts   1,100 700  
Deferred revenue   89,600 68,800  
Deferred commission impairment loss   0    
Advertising Expense   $ 5,500 5,800 4,500
Income tax description   The Company recognizes the effect of income tax positions only if those positions are more likely than not of being sustained. Recognized income tax positions are measured at the largest amount that is greater than 50% likely of being realized. Changes in recognition or measurement are reflected in the period in which the change in judgment occurs.    
Restricted cash, noncurrent   $ 869 855  
Goodwill, impairment loss   0 0 0
Impairment for intangible assets   0 0 0
Capitalized Computer Software, Impairments   0 0 0
Impairment Loss on Long Lived Asset   0 0 0
Reserve   0 0  
Warranties        
Financing Receivable Impaired [Line Items]        
Reserve   $ 0 $ 0  
Direct Listing        
Financing Receivable Impaired [Line Items]        
General and administrative expenses       $ 18,200
Redeemable convertible shares outstanding | shares       68.0
Employee Stock Option        
Financing Receivable Impaired [Line Items]        
Award vesting period 36 months      
RSUs        
Financing Receivable Impaired [Line Items]        
Award vesting period 48 months      
Revenue | Revenue Benchmark | No Customer        
Financing Receivable Impaired [Line Items]        
Concentration Risk, Percentage   10.00% 10.00% 10.00%
Revenue | Revenue Benchmark | One Customer        
Financing Receivable Impaired [Line Items]        
Concentration Risk, Percentage   10.00% 10.00%